Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Impairments in Bowel Function, Social Function and Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Bayat Z, Taylor EL, Bischof DA, McCart JA, Govindarajan A.

Ann Surg Oncol. 2019 May 9. doi: 10.1245/s10434-019-07385-w. [Epub ahead of print]

PMID:
31073912
2.

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.

Pol JG, Acuna SA, Yadollahi B, Tang N, Stephenson KB, Atherton MJ, Hanwell D, El-Warrak A, Goldstein A, Moloo B, Turner PV, Lopez R, LaFrance S, Evelegh C, Denisova G, Parsons R, Millar J, Stoll G, Martin CG, Pomoransky J, Breitbach CJ, Bramson JL, Bell JC, Wan Y, Stojdl DF, Lichty BD, McCart JA.

Oncoimmunology. 2018 Sep 19;8(1):e1512329. doi: 10.1080/2162402X.2018.1512329. eCollection 2019.

3.

Glove and instrument changing to prevent tumour seeding in cancer surgery: a survey of surgeons' beliefs and practices.

Berger-Richardson D, Xu RS, Gladdy RA, McCart JA, Govindarajan A, Swallow CJ.

Curr Oncol. 2018 Jun;25(3):e200-e208. doi: 10.3747/co.25.3924. Epub 2018 Jun 28.

4.

Management of complex polyps of the colon and rectum.

Angarita FA, Feinberg AE, Feinberg SM, Riddell RH, McCart JA.

Int J Colorectal Dis. 2018 Feb;33(2):115-129. doi: 10.1007/s00384-017-2950-1. Epub 2017 Dec 28. Review.

PMID:
29282496
5.

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.

Evgin L, Ilkow CS, Bourgeois-Daigneault MC, de Souza CT, Stubbert L, Huh MS, Jennings VA, Marguerie M, Acuna SA, Keller BA, Lefebvre C, Falls T, Le Boeuf F, Auer RA, Lambris JD, McCart JA, Stojdl DF, Bell JC.

Mol Ther Oncolytics. 2016 Nov 16;3:16027. eCollection 2016.

6.

Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor.

Angarita FA, Hassan S, Cannell AJ, Dickson BC, Gladdy RA, Swallow CJ, Gupta A, Blackstein ME, McCart JA.

Eur J Surg Oncol. 2017 Feb;43(2):423-431. doi: 10.1016/j.ejso.2016.08.017. Epub 2016 Oct 4.

PMID:
27890349
7.

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.

Downs-Canner S, Guo ZS, Ravindranathan R, Breitbach CJ, O'Malley ME, Jones HL, Moon A, McCart JA, Shuai Y, Zeh HJ, Bartlett DL.

Mol Ther. 2016 Aug;24(8):1492-501. doi: 10.1038/mt.2016.101. Epub 2016 May 16.

8.

Impact of Major Complications on Patients' Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Hamilton TD, Taylor EL, Cannell AJ, McCart JA, Govindarajan A.

Ann Surg Oncol. 2016 Sep;23(9):2946-52. doi: 10.1245/s10434-016-5231-2. Epub 2016 Apr 19.

PMID:
27094685
9.

Direct Lymph Node Vaccination of Lentivector/Prostate-Specific Antigen is Safe and Generates Tissue-Specific Responses in Rhesus Macaques.

Au BC, Lee CJ, Lopez-Perez O, Foltz W, Felizardo TC, Wang JCM, Huang J, Fan X, Madden M, Goldstein A, Jaffray DA, Moloo B, McCart JA, Medin JA.

Biomedicines. 2016 Feb 19;4(1). pii: E6. doi: 10.3390/biomedicines4010006.

10.

Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy.

Nadler A, McCart JA, Govindarajan A.

Clin Colon Rectal Surg. 2015 Dec;28(4):234-46. doi: 10.1055/s-0035-1564431. Review.

11.

Programmable insect cell carriers for systemic delivery of integrated cancer biotherapy.

Roy DG, Power AT, Bourgeois-Daigneault MC, Falls T, Ferreira L, Stern A, Tanese de Souza C, McCart JA, Stojdl DF, Lichty BD, Atkins H, Auer RC, Bell JC, Le Boeuf F.

J Control Release. 2015 Dec 28;220(Pt A):210-221. doi: 10.1016/j.jconrel.2015.10.030. Epub 2015 Oct 19.

PMID:
26482080
12.

VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection.

Arulanandam R, Batenchuk C, Angarita FA, Ottolino-Perry K, Cousineau S, Mottashed A, Burgess E, Falls TJ, De Silva N, Tsang J, Howe GA, Bourgeois-Daigneault MC, Conrad DP, Daneshmand M, Breitbach CJ, Kirn DH, Raptis L, Sad S, Atkins H, Huh MS, Diallo JS, Lichty BD, Ilkow CS, Le Boeuf F, Addison CL, McCart JA, Bell JC.

Cancer Cell. 2015 Aug 10;28(2):210-24. doi: 10.1016/j.ccell.2015.06.009. Epub 2015 Jul 23.

13.

Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer.

Ottolino-Perry K, Acuna SA, Angarita FA, Sellers C, Zerhouni S, Tang N, McCart JA.

Mol Oncol. 2015 Oct;9(8):1539-52. doi: 10.1016/j.molonc.2015.04.009. Epub 2015 May 6.

14.

Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.

Dubé P, Sideris L, Law C, Mack L, Haase E, Giacomantonio C, Govindarajan A, Krzyzanowska MK, Major P, McConnell Y, Temple W, Younan R, McCart JA.

Curr Oncol. 2015 Apr;22(2):e100-12. doi: 10.3747/co.22.2058.

15.

Improving identification of fall-related injuries in ambulatory care using statistical text mining.

Luther SL, McCart JA, Berndt DJ, Hahm B, Finch D, Jarman J, Foulis PR, Lapcevic WA, Campbell RR, Shorr RI, Valencia KM, Powell-Cope G.

Am J Public Health. 2015 Jun;105(6):1168-73. doi: 10.2105/AJPH.2014.302440. Epub 2015 Apr 16.

16.

Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques.

Evgin L, Acuna SA, Tanese de Souza C, Marguerie M, Lemay CG, Ilkow CS, Findlay CS, Falls T, Parato KA, Hanwell D, Goldstein A, Lopez R, Lafrance S, Breitbach CJ, Kirn D, Atkins H, Auer RC, Thurman JM, Stahl GL, Lambris JD, Bell JC, McCart JA.

Mol Ther. 2015 Jun;23(6):1066-1076. doi: 10.1038/mt.2015.49. Epub 2015 Mar 25.

17.

Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis.

Tong JG, Valdes YR, Barrett JW, Bell JC, Stojdl D, McFadden G, McCart JA, DiMattia GE, Shepherd TG.

Mol Ther Oncolytics. 2015 Sep 23;2:15013. doi: 10.1038/mto.2015.13. eCollection 2015.

18.

Using information from the electronic health record to improve measurement of unemployment in service members and veterans with mTBI and post-deployment stress.

Dillahunt-Aspillaga C, Finch D, Massengale J, Kretzmer T, Luther SL, McCart JA.

PLoS One. 2014 Dec 26;9(12):e115873. doi: 10.1371/journal.pone.0115873. eCollection 2014.

19.

First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.

Zeh HJ, Downs-Canner S, McCart JA, Guo ZS, Rao UN, Ramalingam L, Thorne SH, Jones HL, Kalinski P, Wieckowski E, O'Malley ME, Daneshmand M, Hu K, Bell JC, Hwang TH, Moon A, Breitbach CJ, Kirn DH, Bartlett DL.

Mol Ther. 2015 Jan;23(1):202-14. doi: 10.1038/mt.2014.194. Epub 2014 Oct 8.

20.

Oncolytic vaccinia virus as an adjuvant treatment to cytoreductive surgery for malignant peritoneal mesothelioma.

Acuna SA, Ottolino-Perry K, Çako B, Tang N, Angarita FA, McCart JA.

Ann Surg Oncol. 2014 Jul;21(7):2259-66. doi: 10.1245/s10434-014-3651-4. Epub 2014 Apr 10.

PMID:
24719018
21.

TagLine: Information Extraction for Semi-Structured Text in Medical Progress Notes.

Finch DK, McCart JA, Luther SL.

AMIA Annu Symp Proc. 2014 Nov 14;2014:534-43. eCollection 2014.

22.

Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation?

Zih FS, Wong-Chong N, Hummel C, Petronis J, Panzarella T, Pollett A, McCart JA, Swallow CJ.

Ann Surg Oncol. 2014 Jan;21(1):225-31. doi: 10.1245/s10434-013-3283-0. Epub 2013 Oct 8. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4:S777. McCart, Andrea J [corrected to McCart, J Andrea].

PMID:
24100959
23.

A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion.

Haslinger M, Francescutti V, Attwood K, McCart JA, Fakih M, Kane JM 3rd, Skitzki JJ.

Cancer Med. 2013 Jun;2(3):334-42. doi: 10.1002/cam4.80. Epub 2013 Apr 16.

24.

Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis.

Ottolino-Perry K, Tang N, Head R, Ng C, Arulanandam R, Angarita FA, Acuna SA, Chen Y, Bell J, Dacosta RS, McCart JA.

Int J Cancer. 2014 Feb 1;134(3):717-30. doi: 10.1002/ijc.28395. Epub 2013 Aug 29.

25.

Physicians' awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis.

Spiegle G, Schmocker S, Huang H, Victor JC, Law C, McCart JA, Kennedy ED.

Can J Surg. 2013 Aug;56(4):237-42.

26.

Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses.

Angarita FA, Acuna SA, Ottolino-Perry K, Zerhouni S, McCart JA.

Trends Mol Med. 2013 Jun;19(6):378-92. doi: 10.1016/j.molmed.2013.02.008. Epub 2013 Mar 27. Review.

PMID:
23540715
27.

Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.

Breitbach CJ, Arulanandam R, De Silva N, Thorne SH, Patt R, Daneshmand M, Moon A, Ilkow C, Burke J, Hwang TH, Heo J, Cho M, Chen H, Angarita FA, Addison C, McCart JA, Bell JC, Kirn DH.

Cancer Res. 2013 Feb 15;73(4):1265-75. doi: 10.1158/0008-5472.CAN-12-2687. Epub 2013 Feb 7.

28.

Finding falls in ambulatory care clinical documents using statistical text mining.

McCart JA, Berndt DJ, Jarman J, Finch DK, Luther SL.

J Am Med Inform Assoc. 2013 Sep-Oct;20(5):906-14. doi: 10.1136/amiajnl-2012-001334. Epub 2012 Dec 15.

29.

Using ensemble models to classify the sentiment expressed in suicide notes.

McCart JA, Finch DK, Jarman J, Hickling E, Lind JD, Richardson MR, Berndt DJ, Luther SL.

Biomed Inform Insights. 2012;5(Suppl. 1):77-85. doi: 10.4137/BII.S8931. Epub 2012 Jan 30.

30.

Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum.

Brun J, Mahoney DJ, Le Boeuf F, Lefebvre C, Sanaei CA, Falls T, Mccart JA, Stojdl DF.

Int J Cancer. 2013 Feb 1;132(3):726-31. doi: 10.1002/ijc.27695. Epub 2012 Sep 28.

31.

Giant stomach secondary to juvenile polyposis syndrome.

Wong-Chong N, Kidanewold WH, Kirsch R, May GR, McCart JA.

J Gastrointest Surg. 2012 Mar;16(3):669-72. doi: 10.1007/s11605-011-1714-4. Epub 2011 Oct 18.

PMID:
22005895
32.

Using ontology network structure in text mining.

Berndt DJ, McCart JA, Luther SL.

AMIA Annu Symp Proc. 2010 Nov 13;2010:41-5.

33.

Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors.

MacTavish H, Diallo JS, Huang B, Stanford M, Le Boeuf F, De Silva N, Cox J, Simmons JG, Guimond T, Falls T, McCart JA, Atkins H, Breitbach C, Kirn D, Thorne S, Bell JC.

PLoS One. 2010 Dec 30;5(12):e14462. doi: 10.1371/journal.pone.0014462.

34.

Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.

Walia JS, Neschadim A, Lopez-Perez O, Alayoubi A, Fan X, Carpentier S, Madden M, Lee CJ, Cheung F, Jaffray DA, Levade T, McCart JA, Medin JA.

Hum Gene Ther. 2011 Jun;22(6):679-87. doi: 10.1089/hum.2010.195. Epub 2011 Mar 25.

35.

Antiproliferative effects of 111In- or 177Lu-DOTATOC on cells exposed to low multiplicity-of-infection double-deleted vaccinia virus encoding somatostatin subtype-2 receptor.

Akinlolu O, Ottolino-Perry K, McCart JA, Reilly RM.

Cancer Biother Radiopharm. 2010 Jun;25(3):325-33. doi: 10.1089/cbr.2009.0713.

PMID:
20578838
36.

Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.

Brun J, McManus D, Lefebvre C, Hu K, Falls T, Atkins H, Bell JC, McCart JA, Mahoney D, Stojdl DF.

Mol Ther. 2010 Aug;18(8):1440-9. doi: 10.1038/mt.2010.103. Epub 2010 Jun 15.

37.

Synergistic interaction between oncolytic viruses augments tumor killing.

Le Boeuf F, Diallo JS, McCart JA, Thorne S, Falls T, Stanford M, Kanji F, Auer R, Brown CW, Lichty BD, Parato K, Atkins H, Kirn D, Bell JC.

Mol Ther. 2010 May;18(5):888-95. doi: 10.1038/mt.2010.44. Epub 2010 Mar 16.

38.

Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.

Heikkilä JE, Vähä-Koskela MJ, Ruotsalainen JJ, Martikainen MW, Stanford MM, McCart JA, Bell JC, Hinkkanen AE.

PLoS One. 2010 Jan 6;5(1):e8603. doi: 10.1371/journal.pone.0008603.

39.

Intelligent design: combination therapy with oncolytic viruses.

Ottolino-Perry K, Diallo JS, Lichty BD, Bell JC, McCart JA.

Mol Ther. 2010 Feb;18(2):251-63. doi: 10.1038/mt.2009.283. Epub 2009 Dec 22. Review.

40.

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.

Guse K, Sloniecka M, Diaconu I, Ottolino-Perry K, Tang N, Ng C, Le Boeuf F, Bell JC, McCart JA, Ristimäki A, Pesonen S, Cerullo V, Hemminki A.

J Virol. 2010 Jan;84(2):856-66. doi: 10.1128/JVI.00692-09. Epub 2009 Nov 11.

41.

Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.

Lun XQ, Jang JH, Tang N, Deng H, Head R, Bell JC, Stojdl DF, Nutt CL, Senger DL, Forsyth PA, McCart JA.

Clin Cancer Res. 2009 Apr 15;15(8):2777-88. doi: 10.1158/1078-0432.CCR-08-2342. Epub 2009 Apr 7.

42.

Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection.

Loisel-Meyer S, Felizardo T, Mariotti J, Mossoba ME, Foley JE, Kammerer R, Mizue N, Keefe R, McCart JA, Zimmermann W, Dropulic B, Fowler DH, Medin JA.

Mol Cancer Ther. 2009 Mar;8(3):692-702. doi: 10.1158/1535-7163.MCT-08-0769. Epub 2009 Mar 10.

43.

Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.

Deng H, Tang N, Stief AE, Mehta N, Baig E, Head R, Sleep G, Yang XZ, McKerlie C, Trudel S, Stewart AK, McCart JA.

Leukemia. 2008 Dec;22(12):2261-4. doi: 10.1038/leu.2008.120. Epub 2008 May 29. No abstract available.

PMID:
18509356
44.

Oncolytic virotherapy for multiple myeloma.

Stief AE, McCart JA.

Expert Opin Biol Ther. 2008 Apr;8(4):463-73. doi: 10.1517/14712598.8.4.463 . Review.

PMID:
18352850
45.

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.

Chalikonda S, Kivlen MH, O'Malley ME, Eric Dong XD, McCart JA, Gorry MC, Yin XY, Brown CK, Zeh HJ 3rd, Guo ZS, Bartlett DL.

Cancer Gene Ther. 2008 Feb;15(2):115-25. Epub 2007 Dec 14.

46.

A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.

Neschadim A, McCart JA, Keating A, Medin JA.

Biol Blood Marrow Transplant. 2007 Dec;13(12):1407-16. Review.

47.

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow.

Breitbach CJ, Paterson JM, Lemay CG, Falls TJ, McGuire A, Parato KA, Stojdl DF, Daneshmand M, Speth K, Kirn D, McCart JA, Atkins H, Bell JC.

Mol Ther. 2007 Sep;15(9):1686-93. Epub 2007 Jun 19.

48.

Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.

Naik AM, Chalikonda S, McCart JA, Xu H, Guo ZS, Langham G, Gardner D, Mocellin S, Lokshin AE, Moss B, Alexander HR, Bartlett DL.

Hum Gene Ther. 2006 Jan;17(1):31-45.

PMID:
16409123
49.

Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide.

McCart JA, Mehta N, Scollard D, Reilly RM, Carrasquillo JA, Tang N, Deng H, Miller M, Xu H, Libutti SK, Alexander HR, Bartlett DL.

Mol Ther. 2004 Sep;10(3):553-61.

50.

Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.

Trieu Y, Wen XY, Skinnider BF, Bray MR, Li Z, Claudio JO, Masih-Khan E, Zhu YX, Trudel S, McCart JA, Mak TW, Stewart AK.

Cancer Res. 2004 May 1;64(9):3271-5.

Supplemental Content

Loading ...
Support Center